Notch触发的肝窦内皮适应不良通过内皮型一氧化氮合酶加重非酒精性脂肪性肝炎
研究在MCD饮食诱导的NASH小鼠模型中发现肝窦内皮细胞稳态破坏、Notch信号激活;内皮特异性过表达NICD加重NASH,而抑制Notch信号恢复LSEC稳态并改善NASH表型;Notch激活通过抑制eNOS转录加重NASH,eNOS激活剂YC-1及两种γ-分泌酶抑制剂DAPT和LY3039478可改善肝脏脂肪变性、炎症和纤维化。
要点
- NASH小鼠LSEC中Notch信号激活,内皮特异性过表达NICD加重NASH。
- 内皮特异性抑制Notch信号恢复LSEC稳态并改善NASH表型。
- Notch激活通过抑制eNOS转录加重NASH,YC-1可减轻脂肪变性和脂质蓄积。
核心结论
- 内皮特异性Notch激活以eNOS依赖的方式触发LSEC适应不良并加重NASH表型。
- 遗传学和药理学抑制Notch信号可有效恢复LSEC稳态并改善NASH进展。
研究设计与样本
- 研究采用甲硫氨酸-胆碱缺乏(MCD)饮食诱导的NASH小鼠模型。
- 构建内皮特异性Notch胞内结构域(NICD)过表达或RBP-J敲除小鼠,分别激活或抑制内皮细胞Notch信号。
- 使用两种γ-分泌酶抑制剂DAPT和LY3039478在MCD饮食诱导的NASH小鼠模型中进行干预。
主要发现
- NASH小鼠LSEC稳态破坏、LSEC特异性基因谱改变,且LSEC中Notch信号激活。
- 内皮特异性过表达NICD加速LSEC适应不良并加重NASH,而内皮细胞特异性抑制Notch信号恢复LSEC稳态并改善NASH表型。
- 内皮特异性Notch激活通过抑制eNOS转录加重NASH,给予eNOS激活剂YC-1可减轻Notch激活导致的肝脏脂肪变性和脂质蓄积。
- DAPT和LY3039478均有效改善MCD饮食诱导NASH小鼠的肝脏脂肪变性、炎症和肝纤维化。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although NASH can lead to severe clinical consequences, including cirrhosis and hepatocellular carcinoma, no effective treatment is currently available for this disease. Increasing evidence indicates that LSECs play a critical role in NASH pathogenesis; however, the mechanisms involved in LSEC-mediated NASH remain to be fully elucidated. APPROACH AND RESULTS: In the current study, we found that LSEC homeostasis was disrupted and LSEC-specific gene profiles were altered in methionine-choline-deficient (MCD) diet-induced NASH mouse models. Importantly, Notch signaling was found to be activated in LSECs of NASH mice. To then investigate the role of endothelial Notch in NASH progression, we generated mouse lines with endothelial-specific Notch intracellular domain (NICD) overexpression or RBP-J knockout to respectively activate or inhibit Notch signaling in endothelial cells. Notably, endothelial-specific overexpression of the NICD accelerated LSEC maladaptation and aggravated NASH, whereas endothelial cell-specific inhibition of Notch signaling restored LSEC homeostasis and improved NASH phenotypes. Furthermore, we demonstrated that endothelial-specific Notch activation exacerbated NASH by inhibiting endothelial nitric oxide synthase (eNOS) transcription, whereas administration of the pharmacological eNOS activator YC-1 alleviated hepatic steatosis and lipid accumulation resulting from Notch activation. Finally, to explore the therapeutic potential of using Notch inhibitors in NASH treatment, we applied two gamma-secretase inhibitors-DAPT and LY3039478-in an MCD diet-induced mouse model of NASH, and found that both inhibitors effectively ameliorated hepatic steatosis, inflammation, and liver fibrosis. CONCLUSIONS: Endothelial-specific Notch activation triggered LSEC maladaptation and exacerbated NASH phenotypes in an eNOS-dependent manner. Genetic and pharmacological inhibition of Notch signaling effectively restored LSEC homeostasis and ameliorated NASH progression.
引用
- Fang ZQ, Ruan B, Liu JJ, et al. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase. Hepatology. 2022. PMID: 35006626. doi:10.1002/hep.32332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。